Challenges of Alzheimer's Disease with Early Diagnosis and Disease Management
PROGRAM DESCRIPTION Despite the substantial progress made in understanding and treating Alzheimer’s disease in recent years, no disease modifying treatments are currently available such that care has been limited to ...
Despite the substantial progress made in understanding and treating Alzheimer’s disease in recent years, no disease modifying treatments are currently available such that care has been limited to treatment of dementia symptoms and pursuit of the best possible quality of life. With increased federal funding for research and emerging new treatments, however, the importance of early diagnosis and participation in clinical trials cannot be emphasized enough. During this Medical Crossfire®, expert faculty will engage in a multidisciplinary roundtable discussion that includes a neurologist and a geriatrician with a neuroscience background. A patient advocate and early-stage patient give voice to the many facets of lifestyle management and future planning. This activity provides key guidance for diagnosing and treating Alzheimer’s disease and promoting the collaborative care between primary care providers, geriatricians, neurologists and psychiatrists who not only have the patients’ needs at heart, but include caregivers as a member of the multidisciplinary team, steadfastly involved in decision-making processes.
After completing this activity, clinicians should be better able to:Describe neurodegenerative changes that are considered the hallmarks of ADDescribe screening and diagnostic tools for the early identification of individuals with ADDescribe emerging biomarkers for earlier and more accurate diagnosisSelect appropriate therapy for patients with AD to slow disease progression and improve patient and caregiver quality of life (QoL)Describe lifestyle modifications that can improve QoL for patients and caregivers
I'm interested in this
Share with others
Write the first review
Share with others